Incyte Genomics Inc (INCY) Sentiment
SentiSense Score 2.25 · Neutral · ▲ rising · as of 2026-06-25
INCY sentiment is neutral (SentiSense Score 2, strengthening from a 30-day average of 1); attention is steady (3 mentions).
- Sentiment
- Neutral
- SentiSense Score
- 2.25
- Mentions
- 3
Sentiment by source
- News
- Bullish
- Neutral
What's driving it
- INCYte receives Japanese approval for Minjuvi lymphoma drug (0)
- Pharma Companies Report Promising Phase 2 Trial Results (+0.78)
- Incyte Corp Reports Strong Revenue Growth and Promises in Its Pipeline (+0.18)
Live SentiSense Score, sentiment history, and per-source breakdown for Incyte Genomics Inc on SentiSense.